Zhiqiang Shu
Stock Analyst at Berenberg
(0.12)
# 4,153
Out of 4,761 analysts
8
Total ratings
14.29%
Success rate
-21.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $21.85 | +18.99% | 1 | Mar 23, 2023 | |
| KRON Kronos Bio | Initiates: Buy | $12 | $1.00 | +1,100.00% | 1 | Sep 14, 2022 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $92.25 | -2.44% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $1.77 | +1,594.92% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $12 | $0.45 | +2,564.89% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $16.87 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $1.37 | +3,330.66% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $1.29 | +3,853.49% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $21.85
Upside: +18.99%
Kronos Bio
Sep 14, 2022
Initiates: Buy
Price Target: $12
Current: $1.00
Upside: +1,100.00%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $92.25
Upside: -2.44%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $1.77
Upside: +1,594.92%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $12
Current: $0.45
Upside: +2,564.89%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $16.87
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $1.37
Upside: +3,330.66%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $1.29
Upside: +3,853.49%